Log in
Enquire now
TargetGene Biotechnologies

TargetGene Biotechnologies

TargetGene Biotechnologies is a gene Edited, immune cell based therapies founded by Dan Weinthal.

OverviewStructured DataIssuesContributors

Contents

targetgenebio.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Immunotherapy
Immunotherapy
Genetics
Genetics
Therapeutics
Therapeutics
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Healthcare
Healthcare
...
Location
Rehovot
Rehovot
0
B2X
B2C
B2C
B2B
B2B
0
CEO
Yoel Shiboleth
Yoel Shiboleth
0
Founder
Dan Weinthal
Dan Weinthal
0
Yoel Shiboleth
Yoel Shiboleth
0
Pitchbook URL
pitchbook.com/profiles...162219-43
Number of Employees (Ranges)
11 – 50
Email Address
Phone Number
Full Address
Oppenheimer 10 Floor 3 Rehovot Israel0
Patents Assigned (Count)
1
COO
Dan Weinthal
Dan Weinthal
0
Technologies Used
CRISPR
CRISPR
Country
Israel
Israel
0

Other attributes

Company Operating Status
Active

TargetGene Biotechnologies is a biotechnology company involved in the development of a therapeutic genome editing platform human gene therapy with a focus on inherited diseases and cell-based immunotherapy.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like TargetGene Biotechnologies

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.